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Cadmium (Cd) is a heavy metal used ubiquitously in consumer and industrial products. 
Natural and anthropogenic activities can introduce Cd into the environment, thus exposing 
humans. Exposure to Cd has been associated with adverse health outcomes including kidney and 
bone damage, cancer, and pregnancy-related diseases, such as preeclampsia. Although there have 
been studies investigating the effects of prenatal exposure to Cd and pregnancy-related health 
outcomes, there are gaps in the literature regarding the underlying mechanisms for those 
associations. In particular, the effects of prenatal Cd exposure on placental cell fusion, also 
known as syncytialization, is vastly understudied. Syncytialization occurs when mononucleated 
trophoblasts fuse together to create the placental barrier between the mother and fetus. The fused 
multinucleated trophoblasts form the outer membrane of the placenta, and are in immediate 
contact with maternal blood; therefore, they are directly involved in the exchange of oxygen, 
nutrients, and waste. Improper syncytialization may contribute to these adverse pregnancy-
related health outcomes. Using in vitro methods, the relationship between prenatal Cd exposure 
and syncytialization was investigated. JEG-3 and BeWo cells, in vitro trophoblast cell lines, were 
treated with varying doses of Cd, or cotreated with forskolin, an inducer of syncytialization, and 
Cd. We measured human chorionic gonadotropin (hCG), a marker of syncytialization, using 
enzyme-linked immunosorbent assays (ELISAs). Data demonstrates that JEG-3 and BeWo cells 
exposed to Cd or Cd-forskolin cotreatments for 48 hours alter the secretion of hCG. These results 
may reflect a mechanism by which Cd exposure can affect proper development of the placenta in 
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 Cadmium (Cd) is a nonessential heavy metal used ubiquitously in the production of many 
consumer and industrial goods. In particular, it has been utilized in cigarettes, fertilizers, non-
corrosive metal plating, and electronics (Chunhabundit, 2016). Because of its widespread use, Cd 
can readily enter the environment through natural and anthropogenic pathways, including 
fertilizer application, smoking, sewage sludge, metal ore combustion, and electronic waste 
recycling (Chunhabundit, 2016). The primary source of non-occupational human exposure to Cd 
is through contaminated food (Satarug, Garrett, Sens, & Sens, 2010); the heavy metal has a high 
rate of soil-to-plant transfer, and can easily accumulate in food, such as shellfish, mushrooms, 
green leafy vegetables, and root crops (Chunhabundit, 2016; Jarup & Akesson, 2009). 
Additionally, cigarette smoking is another major source of exposure (Adams et al., 2011; Rafati 
Rahimzadeh, Rafati Rahimzadeh, Kazemi, & Moghadamnia, 2017). Cd easily accumulates in the 
tobacco plant, and is subsequently released and inhaled during the burning of cigarettes (Adams 
et al., 2011). Exposure to Cd is a major public health issue because of its severe toxicity to the 
human body. 
 Adverse health effects associated with Cd exposure have been documented since the mid 
nineteenth century (Nordberg, 2009). In recent years, there is strong evidence establishing links 
between Cd exposure and respiratory, kidney, bone, and reproductive damage (Godt et al., 
2006). Furthermore, the International Agency for Research on Cancer classified Cd as a group 1 
compound, suggesting that there is sufficient evidence to conclude that it is carcinogenic to 
humans (International Agency for Research on Cancer, 1993). Studies have shown associations 
with lung, kidney, breast, and prostate cancer (Il'yasova & Schwartz, 2005; Maruzeni et al., 
2014; Nawrot et al., 2006; Rapisarda et al., 2018). In recent years, there has been an increased 
7 
 
focus in understanding how heavy metals, like Cd, affect pregnant women and developing 
fetuses. Cd exposure is associated with the increased risk for adverse pregnancy- and birth-
related outcomes, such as preeclampsia, miscarriage, and fetal undernourishment (Edwards, 
Maxson, Miranda, & Fry, 2015). Furthermore, in utero exposure to Cd has been linked to 
impaired growth and neurodevelopment (Gardner et al., 2013; Kippler et al., 2016; Kippler et al., 
2012). Perturbations in the placenta may explain the underlying mechanisms that modulate these 
adverse health associations. 
 The placenta is a complex, temporary organ that is responsible for ensuring a safe and 
healthy pregnancy (Burton & Jauniaux, 2015). It plays a vital role in serving as a barrier between 
maternal and fetal blood by promoting the exchange of gases, nutrients, and waste (Gude, 
Roberts, Kalionis, & King, 2004). The placenta consists of two portions: the fetal tissue derived 
from the chorionic sac and the maternal tissue derived from the endometrium. In between these 
two regions lies the intervillous space, which is lined with the placental membrane. During the 
initial stages of development, the placental membrane consists of four layers: (1) the 
syncytiotrophoblast, an enlarged multinucleated cell, which is in direct contact with maternal 
blood, (2) cytotrophoblast cells, (3) connective villus tissue, and (4) the endothelial lining of the 
fetal capillaries. Maternal and fetal exchange occurs at the terminal ends of the intervillous space 
(Gude et al., 2004). 
As the placenta develops, the mononucleated cytotrophoblast layer begins to differentiate 
into the syncytiotrophoblast, narrowing the distance between the maternal and fetal blood to 
promote efficient exchange (Gude et al., 2004). This differentiation process is known as 
syncytialization (Gupta, Malhotra, Malik, Verma, & Chaudhary, 2016). As the 
syncytiotrophoblast develops, the cytotrophoblasts synthesize the human chorionic gonadotropin 
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(hCG) hormone, which functions to maintain the corpus luteum, angiogenesis, and further 
trophoblast differentiation (Guibourdenche et al., 2010). The production of hCG induces 
cytotrophoblast invasion of the uterus to ensure proper embryo implantation and supply of 
nutrients and oxygen (Adams et al., 2011; Hiden, Bilban, Knofler, & Desoye, 2007; Movsas & 
Muthusamy, 2018). 
hCG production serves as a marker for syncytialization and placental development. hCG 
secreted by cytotrophoblasts bind to the luteinizing hormone/choriogonadotropin receptor on 
adjacent trophoblasts, resulting in the formation of intracellular cyclic adenosine monophosphate 
(cAMP). Subsequently, cAMP binds to the regulatory subunit of protein kinase A (PKA), and 
thereby activates and releases the catalytic subunit of PKA. The release of the catalytic subunit 
phosphorylates transcription factors, such as the cAMP response element-binding protein 
(CREB) and chorion-specific transcription factor (GCMa). This upregulates the transcription of 
genes involved in the fusion of trophoblasts, including Syncytin1, Syncytin 2, GCM1, 
Connexin43, CGA, and CGB (Gerbaud & Pidoux, 2015). Syncytialization plays an essential role 
in ensuring a healthy pregnancy because it forms the syncytiotrophoblasts, which are in direct 
contact with the maternal blood; thus, its proper development enables the feto-maternal exchange 
needed for fetal growth (Gerbaud & Pidoux, 2015). Inadequate formation of the 
syncytiotrophoblast has the potential to result in the onset of pregnancy diseases, including 
preeclampsia (Huppertz, Meiri, Gizurarson, Osol, & Sammar, 2013). 
Preeclampsia is defined by the development of hypertension (140/90 mmHg) at or after 
20 weeks of gestation (Huppertz et al., 2013). If the disease increases in severity, it can lead to 
the onset of eclampsia, which is a deadly pregnancy complication associated with seizures 
(Schenone, Miller, Samson, & Mari, 2013). Furthermore, preeclampsia is a major cause of 
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maternal mortality globally (Huppertz et al., 2013; Rosen, Munoz, McElrath, Cantonwine, & 
Ferguson, 2018). An estimated 2-8% of the global population of pregnant women are diagnosed 
with the disease (Rosen et al., 2018). Current research suggests several potential explanations for 
the development of preeclampsia, including improper placentation or inadequate supply of 
maternal blood, inflammatory response to oxidative stress, and abnormal maternal response from 
pre-existing conditions (e.g. hypertension, obesity, and diabetes) (Redman & Sargent, 2005). 
Additionally, exposures to environmental contaminants, like Cd, have also been associated with 
preeclampsia (Adams et al., 2011; Laine et al., 2015; Rosen et al., 2018; F. Wang et al., 2018). In 
understanding how Cd perturbs biological mechanisms to result in preeclampsia, evidence 
suggests oxidative stress to impaired placental function, pro-inflammatory reactions, and 
perturbations of the glucocorticoid, or stress response, pathway may all contribute (Laine et al., 
2015; F. Wang et al., 2018). 
However, there is a gap in the literature regarding the effects of Cd exposure on 
syncytialization in the placenta as a potential mechanism for the onset of pregnancy-related 
diseases, like preeclampsia. In this study, we investigated whether Cd exposure influences 
syncytialization in the placenta by measuring hCG secretion. We hypothesize that Cd would 




Cell Culture and Cd Treatment. The JEG-3 and BeWo choriocarcinoma cell lines were 
purchased from the American Type Culture Collection (Manassas, VA). JEG-3 cells were grown 
in Gibco Minimum Essential Medium with 10% fetal bovine serum (FBS), 1% 
penicillin/streptomycin, and 1mM sodium pyruvate at 37 °C in 50% CO2. BeWo cells were 
grown in Kaighn’s modification of Ham’s F-12 Medium with 10% FBS and 1% 
penicillin/streptomycin at 37 °C in 50% CO2. Cells were plated at 2 × 106 cells per 10 cm2 
flask, and incubated under standard conditions until achieving 80-90% confluence. Cadmium 
Chloride (CdCl2) was resuspended in deionized water to create a stock concentration of 10 mM. 
To study the effects of Cd exposure in vitro, cells were seeded in a 12-well culture plate at 
0.25 × 106 cells per well, and incubated for 24 hours (h) prior to treatment. On the day of 
treatment, the stock CdCl2 was added to the cell type’s corresponding media, and vortexed to 
create final concentrations of 0.044 μM, 1 μM, and 10 μM. Cells were incubated in the presence 
or absence of Cd for 24 or 48 h, and then harvested for messenger ribonucleic acid (mRNA) 
isolation. Treated and untreated cells were harvested in 350 μL of Buffer RLT, and placed in a 
QIAcube (Qiagen, Valencia, CA) for mRNA and DNA extraction using the AllPrep 
DNA/RNA/miRNA Universal Kit (Qiagen, Valencia, CA). mRNA was further cleaned with the 
RNA Clean and Concentrator-5 kit (Zymo Research, Irvine, CA). mRNA was quantified using a 
Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA). For protein harvests, 
cells were seeded in a six-well plate at 0.5 × 106 cells per well, and incubated for 24 h prior to 
treatment. On the day of treatment, the stock CdCl2 was added to the cell type’s corresponding 
media, and vortexed to create final concentrations of 0.044 μM, 1 μM, and 10 μM. Cells were 
incubated in the presence or absence of Cd for 24 or 48 h, and then harvested for protein in 150 
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μL RIPA buffer, supplemented with 1% phosphatase inhibitor and 1% protease inhibitor (Fisher 
Scientific, New Hampshire). Cell supernatant was also collected from protein and RNA samples. 
To address potential variation due differences in where the cells are in their life stage, forskolin 
(F) was added to the Cd treatments. F is a known cAMP inducer; thus, treatment in cells induce 
cells into syncytialization (Dubey, Malhotra, & Gupta, 2018; Omata, Ackerman, Vandre, & 
Robinson, 2013; R. Wang et al., 2014). By adding F to the Cd treatments, the cell cycles would 
sync, and move towards syncytialization together. Therefore, both cell lines were cotreated with 
100 μM F and 0.044 μM, 1 μM, and 10 μM of CdCl2; they were treated for 24 or 48 h. The cells 
were harvested for mRNA, DNA, and protein with the same procedures previously described; 
supernatant was collected from the protein and mRNA samples. 
Cytotoxicity Assay. To determine the cytotoxicity of the Cd treatments, JEG-3 and BeWo cells 
were seeded at 1.0 × 104 cells per well in 96-well culture plates, and incubated overnight for 24 
h. The cells were treated as described above and incubated for 24 or 48 h. Resazurin dye, at a 
final concentration of 10 μg/L, was added to the culture, and then incubated for an additional two 
hours at 37 °C. During this time, viable cells convert resazurin to resorufin, the fluorescent 
product. After a two-hour incubation, fluorescence was measured at an excitation wavelength of 
560 nm and an emission wavelength of 590 nm, according to the manufacturer’s protocol, with a 
Promega spectrophotometer microplate reader. Each well’s fluorescence value is in 
correspondence with the number of viable cells in the population. 
Protein Quantification and Human Chorionic Gonadotropin Secretion. Treated and 
untreated cells were harvested for protein in 150 μL RIPA buffer, supplemented with 1% 
phosphatase inhibitor and 1% protease inhibitor (Fisher Scientific, New Hampshire). For protein 
quantification, samples were measured with a Pierce BCA assay kit to the manufacturer’s 
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protocol (Thermo Scientific, Waltham, MA). Supernatant from treated and untreated cells were 
measured for hCG concentrations using an hCG enzyme-linked immunosorbent assay (ELISA); 
the ELISA was followed according to manufacturer’s protocol (RayBiotech, Norcross, GA). 
Statistical Analysis. The JEG-3 experiments were performed with four biological replicates, and 
the BeWo experiments were performed with five biological replicates. Statistically findings are 
reported as the mean value ± standard error of mean (SEM). hCG secretion values for the Cd 
and Cd-forskolin cotreatments were adjusted for protein concentration derived from the Pierce 
BCA assay, and analyzed using a one-way analysis of variance (ANOVA) in Prism8 (GraphPad, 
San Diego, CA). F treatments were analyzed against the controls for each cell line at each time 
point using an unpaired Welsh’s t-test. For all analyses, statistical significance was set at a 





hCG Production in Cd Exposed BeWo Cells. To ensure that the Cd doses administered to the 
BeWo cells were not cytotoxic, a resazurin cytotoxicity assay was performed. The data 
(Supplemental Figure 1) demonstrated that 0.044 μM CdCl2, 1 μM CdCl2, and 10 μM CdCl2 
did not induce cytotoxicity in the BeWo cells. In order to understand whether the doses chosen 
impacted hCG secretion, supernatant from treated cells were collected, and associated protein 
concentrations were measured. hCG concentration was analyzed with an ELISA specific for 
hCGβ. Results showed that Cd did not significantly (p < 0.05) alter hCG secretion after 24 and 
48 h of treatment (Figure 1). 
 
Figure 1. hCG secretion after CdCl2 treatment for 24 and 48 h in BeWo cells. Values shown are 
means with SEM. Concentrations determined by the ELISAs (pg/mL) were adjusted to protein 
concentration (μg/mL) determined by the Pierce BCA assay. hCG production was not 
significantly altered (p < 0.05) by Cd after 24 or 48 h. 
hCG Secretion in Forskolin Treated Cytotrophoblasts. F is a known inducer of 
syncytialization by increasing production of cAMP, and has been shown to increase hCG 
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secretion in various cytotrophoblast cell lines, including BeWo and JEG-3 cells (Omata et al., 
2013; R. Wang et al., 2014). For both cell types after 24 and 48 h exposure to F, there is a 
statistically significant (p < 0.05) increase in hCG secretion. Additionally, the BeWo cells 
secreted a greater concentration of hCG in comparison to the JEG-3 cells at both 24 and 48 h 
harvests. 
 
Figure 2. hCG secretion after 24 and 48 h 100 μM treatment to F. Values shown are means with 
SEM. hCG Concentrations (pg/mL) determined by ELISAs were adjusted for protein 
concentration (μg/mL). * indicates significance at p < 0.05; ** p < 0.05, *** p < 0.0005. 
hCG Production in Cd-Forskolin Cotreated BeWo Cells. In order to induce the cells into 
syncytialization, Cd-forskolin cotreatments were conducted. Initially, cells were treated with 100 
μM F, followed immediately with the following CdCl2 doses: 0.044 μM, 1 μM, and 10 μM. After 
24 and 48 h, the supernatant was collected and protein was harvested. The hCG secretion was 
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analyzed using an hCG ELISA. After 24 h exposure to the Cd-forskolin cotreatments, there was 
no significant change in hCG secretion (Figure 3A). After 48 h, 10 μM Cd-Forskolin treatment 
significantly (P < 0.05) increased hCG production (Figure 3B). 
 
Figure 3. hCG production after 24 and 48 h Cd-forskolin cotreatments in BeWo cells. The 
control lacks both F and CdCl2. F is the positive control. All Cd-forskolin cotreatments include 
100 μM F followed by the indicated concentration of CdCl2. hCG concentrations (pg/mL) were 
determined by an hCGβ ELISA, and were adjusted by protein concentration (μg/mL) determined 
by the Pierce BCA assay. * indicates significance at p < 0.05 in comparison to F. 
hCG Production in Cd-treated JEG-3 Cells. In order to ensure the selected Cd doses were not 
cytotoxic to JEG-3 cells, a resazurin cytotoxicity assay was conducted. The selected Cd doses 
(0.044 μM CdCl2, 1 μM CdCl2, and 10 μM CdCl2) were not cytotoxic to JEG-3 cells 
(Supplemental Figure 2). To understand the effects of the non-cytotoxic Cd doses on the JEG-3 
cells, supernatants from the cells were collected. Furthermore, CdCl2 exposure did not 
significantly alter hCG secretion in JEG-3 cells after 24 h of exposure (Figure 4A). The CdCl2-
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treated JEG-3 cells showed a significant decrease in hCG production at the highest dose of 10 
μM CdCl2 (Figure 4B). 
 
Figure 4. hCG production in JEG-3 after exposure to CdCl2. (A) The hCG concentrations 
derived from the ELISA were not adjusted to protein concentration. The JEG-3 cells were 
exposed to CdCl2 for 24 h, and showed a decrease in hCG secretion, although it was not 
significant. (B) The hCG concentrations (pg/mL) were adjusted to protein concentration 
(μg/mL). After exposure to CdCl2, there was a significant decrease in hCG secretion at the 
highest dose (10 μM). ** indicates significance at p < 0.05. 
hCG Production in Cd-Forskolin Cotreated JEG-3 Cells. hCG secretion from Cd-Forskolin 
cotreated JEG-3 cells were analyzed via hCG ELISA. The concentrations (pg/mL) derived from 
the ELISA were adjusted to protein concentration (μg/mL). Unlike the response seen in BeWos, 
hCG secretion by the JEG-3 was not significantly affected by 24 or 48 h exposure to Cd (Figure 




Figure 5. hCG production after Cd-forskolin cotreatments for 24 and 48 h in JEG-3 cells. The 
hCG concentrations derived from the hCG ELISA (pg/mL) were adjusted for protein 
concentration (μg/mL) determined by the Pierce BCA assay. The control lacks both F and CdCl2. 
F is the positive control. For each treatment, F concentration was 100 μM. The Cd doses (0.044 
μM, 1 μM, and 10 μM CdCl2) varied as indicated. 




 Cd is a toxic metal that is widely used in consumer and industrial processes and products 
(Chunhabundit, 2016). Cd exposure is associated with kidney and bone damage, as well as 
various types of cancer (Godt et al., 2006; Il'yasova & Schwartz, 2005; Maruzeni et al., 2014; 
Nawrot et al., 2006; Rapisarda et al., 2018). Additionally, prenatal exposure to Cd has been 
linked with adverse pregnancy outcomes, such as increased risk for miscarriage and 
preeclampsia (PMID: 25073434). There is a need to investigate the mechanisms that underly the 
relationship between prenatal Cd exposure and pregnancy-related outcomes, like preeclampsia. 
In the current literature, there is a gap in understanding how Cd exposure affects syncytialization, 
or the process by which mononucleated cytotrophoblasts differentiate into a multinucleated 
syncytiotrophoblast (Gupta et al., 2016). Syncytialization is a key process in the development of 
the placenta because it leads to the formation of syncytiotrophoblasts, which are in direct contact 
with the maternal blood. The syncytiotrophoblast allows for the exchange of nutrients, waste, 
and gases between the mother and fetus. During syncytialization, hCG hormone production 
increases to facilitate further placental development, thereby making it an ideal marker to 
measure (Hiden et al., 2007; Movsas & Muthusamy, 2018). There is evidence to suggest that 
inadequately formed syncytiotrophoblasts may play a role in the onset of pregnancy diseases, 
specifically preeclampsia (Huppertz et al., 2013). In this study, we aimed to investigate if non-
cytotoxic doses of Cd could modulate syncytialization by measuring changes in hCG secretion. 
We used in vitro methods to analyze the effects of Cd on placental cell syncytialization, 
and identified three major findings: (1) hCG production is altered by Cd-Forskolin cotreatments 
in BeWo cells, (2) Cd alters hCG production in JEG-3 cells, and (3) the effect of Cd varies by 
cell lines. hCG production was altered when BeWo cells were treated with Cd-forskolin 
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cotreatments. When cultured with or without forskolin, BeWo cell lines have the ability to form 
the syncytiotrophoblast, and produce higher concentrations of hCG, making them an appropriate 
model to study syncytialization(Bode et al., 2006; Drwal, Rak, & Gregoraszczuk, 2018). The 
results demonstrated that Cd-forskolin co-exposures in BeWos resulted in a significantly higher 
secretion of hCG after 48 h in comparison to forskolin alone. This suggests that forskolin and Cd 
together may have a synergistic effect on the BeWo trophoblasts, or the effects of Cd are 
overpowered by the inducing effects of forskolin. 
The second takeaway from the study is the effect of Cd on hCG production by JEG-3 
cells. Because the JEG-3 cells are able to proliferative, migrate, and have endocrine functions, 
they can be used as first trimester model (Blanchon et al., 2002; Sokolov et al., 2015; Weiss et 
al., 2001). If JEG-3 cells are treated with forskolin, they will begin to secrete high concentrations 
of hCG, but they will not fuse to create the syncytiotrophoblast (Al-Nasiry, Spitz, Hanssens, 
Luyten, & Pijnenborg, 2006). When JEG-3 cells were exposed to Cd, they produced significantly 
less hCG at the highest dose (10 μM). In a normative pregnancy, hCG levels exponentially 
increase and peak during the first trimester, and then begin to decrease to steady state 
concentration, where levels remain until the pregnancy reaches full term (Korevaar et al., 2015). 
Interestingly, deviations in hCG serum levels have a bidirectional association with increased risk 
for preeclampsia that is dependent upon the gestational age. On the one hand, a epidemiology 
study found that decreased hyperglycosylated-hCG, an isoform of hCG produced by extravillous 
cytotrophoblasts early in pregnancy, serum levels during the first trimester was linked to 
increased risk for preeclampsia (Keikkala et al., 2013). On the other hand, elevated hCG serum 
levels measured later in pregnancy (e.g. second and third trimesters) were linked with increased 
risk for preeclampsia (Basirat, Barat, & Hajiahmadi, 2006; Choudhury, Das, , Bhattacharya, & 
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Ghosh, 2012; Heinonen, Ryynanen, Kirkinen, & Saarikoski, 1996). Based on the results of this 
study, JEG-3 and BeWo cells may be mimicking the placental environment at different 
gestational stages; therefore, they have opposing reactions to the treatments. 
Finally, the results demonstrated that the exposures had a differential response depending 
on the choriocarcinoma cell line used. Interestingly, Cd-forskolin treatment increased hCG 
secretion in BeWo cells significantly, but had no significant impact on JEG-3 cells. Conversely, 
Cd treatment decreased hCG secretion in JEG-3 cells significantly, but had no impact on BeWo 
cells. These results may be due to cellular differences between the JEG-3 and BeWo cells. JEG-3 
cells are a representation of extravillous trophoblasts, while BeWo cells are more closely related 
to villous trophoblasts (Drwal et al., 2018). Furthermore, JEG-3 and BeWo cells differentially 
express approximately 2700 genes. In BeWo cells, Syndecan-1 (SDC1), metal regulatory 
transcription factor 1 (MTF1), Metallothionein 1E (MT1E), Metallothionein 1X (MT1X), Leptin 
Receptor (LEPR), Glycoprotein hormones alpha peptide (CGA), Chorionic gonadotropin beta 
polypeptide (CGB), placental growth hormone (GH2), Hydroxysteroid (17-beta) dehydrogenase-
1 (HSD17B1), and placental growth factor (PGF) are all upregulated; many of these genes play a 
role in syncytialization (Burleigh et al., 2007). Meanwhile, upregulated genes include Insulin-
like growth factor 2 (IGF2), Endothelial receptor type B (EDNRB), Cadherin 1 (E-cadherin) 
(CHD1), Hypoxia-inducible factor-1 (HIG1), Hypoxia-inducible protein 2 (HIG2), TGF-beta 
receptor 1 (TGFBR1), and Pregnancy-induced growth factor (OKL38) (Burleigh et al., 2007). 
Previous studies have shown differential responses between the two cell lines after exposure to 
inducers of syncytialization, proliferation, and invasion (Al-Nasiry et al., 2006; Mandl, Haas, 
Bischof, Nohammer, & Desoye, 2002). After exposure to forskolin, E-cadherin, a cell adhesion 
molecule, was downregulated in BeWo cells, while its expression was unchanged in JEG-3 cells 
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(Al-Nasiry et al., 2006). cAMP induction in BeWo cells is associated with decreased cell 
proliferation, but is associated with increased proliferation in JEG-3 cells (Al-Nasiry et al., 2006; 
Taylor, Newman, & Chen, 1991). The differential characteristics of the BeWos and JEG-3 cell 
lines may explain the varied response to Cd, especially in the presence of forskolin. When 
forskolin is present, BeWo cells may be progressing further into syncytialization compared to 
JEG-3 cells, which don’t necessarily follow the same pathway. With the Cd treatments and 
cotreatments, variation may be coming from differential functional characteristics based on 
where the cells are in their cell cycle.  
While this study suggests that Cd exposure in placental choriocarcinoma cells lines, 
BeWo and JEG-3, may be impacting placental syncytialization, it is important to consider the 
limitations of the study. JEG-3 and BeWo cell lines are limited in their representation of the 
placenta. Because they are homogenous, their response lacks the complex interactions between 
various cell types present in the placenta and distal organ systems. Moreover, they may not 
reflect the interaction between the placenta and the fetus. Although hCG is a marker of 
syncytialization, this study lacks data on the impact of Cd exposure on gene expression and cell 
morphology in relation to the development of the multinucleated syncytiotrophoblast due to the 
occurrence of the COVID-19 pandemic.  
Future studies should aim to address the limitations of the investigation we conducted. 
The development of the syncytiotrophoblast is the essential end outcome of syncytialization. It 
will be important to explore how Cd exposure may be impacting cell morphology as 
cytotrophoblasts develop. As a direct measure of syncytialization, studies should also focus on 
imaging cells as a measure of determining whether the cytotrophoblasts fuse together to create 
multinucleated cells. Furthermore, the investigation into the expression of genes and proteins 
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known to play a role in syncytialization should be completed. Several known biomolecules of 
interest are syncytin-1, syncytin-2, glial cells missing transcription factor 1 (GCM1), human 
chorionic gonadotropin α-subunit (hCGα), and human chorionic gonadotropin β-subunit (hCGβ) 
(Azar et al., 2018; Lu et al., 2016; Malhotra, Suman, & Gupta, 2015). Furthermore, hCG 
secretion might not be the only factor responsible for cell fusion. CREB phosphorylation and 
intracellular cyclic adenosine monophosphate (cAMP) concentrations are important mechanisms 
to consider (Gerbaud & Pidoux, 2015). To better understand how Cd exposure is affecting the 
hCG production, intracellular cAMP concentrations and the CREB phosphorylation should be 
measured. Finally, the results of this study should be replicated in animal and placental explant 
studies. 
In summary, this work contributes to the understanding of how Cd exposure effects hCG 
production in JEG-3 and BeWo cells as measure of its impact on syncytialization. We have 
shown that Cd can have a complex effect on the syncytialization and the placenta based upon the 
based on cellular characteristics during the course of pregnancy. Cd has a dynamic activity in the 
placenta that needs to be further explored. This work builds on prior studies by demonstrating the 
dynamic responses of placental choriocarcinoma cell lines, as a representation of placental 


















Supplemental Figure 1. BeWo cell % survivability after 48 h of CdCl2 treatment. The red, 
dashed line indicates 100% survivability. All doses below 40 μM CdCl2 are not cytotoxic. 

















Supplemental Figure 2. JEG-3 cell % survivability after 24 and 48 h of CdCl2 treatment. The 
red, dashed line indicates 100% survivability. Doses at or below 20 μM are not cytotoxic for a 24 
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